COMMUNIQUÉ DE PRESSE publié le 14/06/2024 à 14:52, il y a 1 année 7 mois Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research increases Cardiol Therapeutics Inc's price target to USD8.50 in Buy recommendation after positive results from phase II trial of CardiolRx for recurrent pericarditis treatment Cardiol Therapeutics Inc First Berlin Equity Research Buy Recommendation Phase II Trial CardiolRx
COMMUNIQUÉ DE PRESSE publié le 27/02/2024 à 14:16, il y a 1 année 11 mois Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates BUY recommendation on Cardiol Therapeutics Inc. FDA grants Orphan Drug Designation for CardiolRx in pericarditis treatment. Positive phase II study results expected in Q2 2024 FDA Cardiol Therapeutics Inc First Berlin Equity Research Orphan Drug Designation Pericarditis
BRÈVE publiée le 27/02/2024 à 14:16, il y a 1 année 11 mois Cardiol Therapeutics Receives FDA Orphan Drug Designation for CardiolRx FDA Investment Orphan Drug Designation Cardiol Therapeutics Pericarditis
BRÈVE publiée le 27/02/2024 à 14:16, il y a 1 année 11 mois Cardiol Therapeutics obtient la désignation de médicament orphelin par la FDA pour CardiolRx Investissement FDA Orphan Drug Designation Cardiol Therapeutics Pericardite
COMMUNIQUÉ DE PRESSE publié le 19/01/2024 à 12:41, il y a 2 années Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research has published an update on Cardiol Therapeutics Inc., reaffirming its BUY recommendation and maintaining the price target of USD 3.60. The report highlights the progress in patient recruitment for CardiolRx's two lead indications, acute myocarditis (AM) and recurrent pericarditis (RP), with expectations of significant near-term catalysts for the stock. Analyst Christian Orquera remains optimistic about the company's investment potential. For the full analysis, visit the link provided. Cardiol Therapeutics Inc First Berlin Equity Research Buy Recommendation Patient Recruitment Investment Potential
COMMUNIQUÉ DE PRESSE publié le 30/08/2023 à 15:06, il y a 2 années 5 mois Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
COMMUNIQUÉ DE PRESSE publié le 24/05/2023 à 13:01, il y a 2 années 8 mois Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
COMMUNIQUÉ DE PRESSE publié le 11/04/2023 à 15:26, il y a 2 années 9 mois Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
Publié le 04/02/2026 à 18:04, il y a 1 heure 25 minutes Total number of voting rights and shares making up the share capital at January 31, 2026
Publié le 04/02/2026 à 17:45, il y a 1 heure 44 minutes Information concerning the total number of voting rights and shares 2026 01 31
Publié le 04/02/2026 à 17:45, il y a 1 heure 44 minutes MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Publié le 04/02/2026 à 16:15, il y a 3 heures 14 minutes Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Publié le 04/02/2026 à 15:45, il y a 3 heures 44 minutes Patriot.Tv's Jd Rucker Explains Billie Eilish's Comments on ICE, Offers ICE Commentary as Exhibit A of Celebrity Sound Bite Politics
Publié le 04/02/2026 à 15:00, il y a 4 heures 29 minutes Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale
Publié le 04/02/2026 à 18:55, il y a 34 minutes Funding Circle Holdings plc: POS-Transaction in Own Shares
Publié le 04/02/2026 à 18:40, il y a 49 minutes Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology
Publié le 04/02/2026 à 18:05, il y a 1 heure 24 minutes INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL